{
    "2018-10-06": [
        [
            {
                "time": "",
                "original_text": "复星医药股票分析：复星凯特CAR-T获批临床，未来有望快速推进",
                "features": {
                    "keywords": [
                        "复星医药",
                        "复星凯特",
                        "CAR-T",
                        "获批临床",
                        "快速推进"
                    ],
                    "sentiment_score": 0.9,
                    "policy_related": "false",
                    "investment_strategy": "false",
                    "sector_focus": [
                        "生物医药"
                    ],
                    "causal_factor": "true",
                    "causal_impact": "positive",
                    "affected_by_time_series": "true",
                    "ts_effect_direction": "positive"
                }
            }
        ]
    ]
}